Showing results (191-200 of 259) with videos related to
Sort By:
Pageof 26
Medrxiv : the Preprint Server for Health Sciences|April 14, 2021
mRNA vaccination compared to infection elicits an IgG-predominant response with greater SARS-CoV-2 specificity and similar decrease in variant spike recognitionKatharina Röltgen, Sandra C A Nielsen, Prabhu S Arunachalam, et al.Nature Immunology|March 15, 2022
Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccineChunfeng Li, Audrey Lee, Lilit Grigoryan, et al.JCI Insight|March 8, 2024
Impaired innate and adaptive immune responses to BNT162b2 SARS-CoV-2 vaccination in systemic lupus erythematosusKavita Y Sarin, Hong Zheng, Yashaar Chaichian, et al.Cellular & Molecular Immunology|January 5, 2022
Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primatesStéphane Pillet, Prabhu S Arunachalam, Guadalupe Andreani, et al.Scientific Data|October 20, 2022
The Immune Signatures data resource, a compendium of systems vaccinology datasetsJoann Diray-Arce, Helen E R Miller, Evan Henrich, et al.Proceedings of the National Academy of Sciences of the United States of America|February 25, 2016
CXCL13 is a plasma biomarker of germinal center activityColin Havenar-Daughton, Madelene Lindqvist, Antje Heit, et al.Plos Pathogens|February 24, 2018
Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaquesP J Klasse, Thomas J Ketas, Christopher A Cottrell, et al.Science Translational Medicine|January 13, 2022
Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudovirusesBenjamin L Sievers, Saborni Chakraborty, Yong Xue, et al.Biorxiv : the Preprint Server for Biology|January 30, 2023
Extremely potent pan-sarbecovirus neutralizing antibodies generated by immunization of macaques with an AS03-adjuvanted monovalent subunit vaccine against SARS-CoV-2Yupeng Feng, Meng Yuan, John M Powers, et al.Science Translational Medicine|July 31, 2024
A comparative immunological assessment of multiple clinical-stage adjuvants for the R21 malaria vaccine in nonhuman primatesPrabhu S Arunachalam, NaYoung Ha, S Moses Dennison, et al.Pageof 26